Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid

Launched by NANJING FIRST HOSPITAL, NANJING MEDICAL UNIVERSITY · May 22, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a new treatment for keloids, which are raised scars that can develop after an injury or surgery. The study will compare two groups: one group will receive a treatment called Strontium-90 brachytherapy along with hyperthermia (a method that uses heat), while the other group will only receive the Strontium-90 treatment. The goal is to see if combining these two treatments is more effective in reducing keloids than using Strontium-90 alone.

To be eligible for this trial, participants should have a keloid that is clean and has a thickness of 2 to 5 mm with a diameter of at least 10 mm. However, women who are pregnant, planning to become pregnant soon, or breastfeeding cannot participate. Additionally, individuals with certain health conditions, such as issues with blood clotting or prior radiation treatments, are also excluded. If you join the trial, you'll help researchers learn more about how these treatments work and potentially benefit from a new approach to managing keloids.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The patient was clinically diagnosed with keloid, and the keloid area was clean without rupture and exudation；
• • Body surface keloid thickness: 2\~5mm, diameter ≥10mm.
• Exclusion Criteria:
• • Women who plan to become pregnant within 3 months or are pregnant or breastfeeding;
• • Patients with cicatricial constitution;
• • Abnormal coagulation function;
• • Patients who have received an adequate dose or course of radiation therapy;
• • People with previous immune system diseases, diabetes and other metabolic diseases.

Trial Officials